Richard Henry Marshall
CIK: 0002142265
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TLSI
TriSalus Life Sciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Marshall Richard Henry
Marshall Richard Henry (SEC CIK 0002142265) files insider reports with the SEC as Chief Medical Officer of TriSalus Life Sciences, Inc. (TLSI).
Signal8 holds 2 ownership filings by Marshall Richard Henry (1 Form 3, 1 Form 4), filed on Jun 29, 2026. Those filings report 1 transaction, the latest on Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Marshall Richard Henry's filings is in WESTMINSTER, CO.
Recent filings by Marshall Richard Henry
- Jun 29, 2026: Grant or award of TLSI shares (Form 4, code A).
Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)
- Cox Bryan F., Chief of Research
- Marshak Richard, Chief Commercial Officer
- Stevens Jennifer, Chief Regulatory Officer
- Szela Mary T, CEO and President
- Patience David, Chief Financial Officer
- Wahlstrom Mats, Director